Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03288948 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Binocular Amblyopia Treatment

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026v8
  2. Primary completion date: Dec 31, 2024 to Dec 31, 2025
    • Study completion date: Jun 30, 2025 to Dec 31, 2025
    • Site contact updated
    • Collaborators expanded, about 4 words
    v7
  3. Primary completion date: Dec 31, 2022 to Dec 31, 2024
    • Study completion date: Jun 30, 2023 to Jun 30, 2025
    v6
  4. Primary completion date: Dec 31, 2021 to Dec 31, 2022
    • Study completion date: Jun 30, 2022 to Jun 30, 2023
    v5
  5. Primary completion date: Aug 31, 2020 to Dec 31, 2021
    • Study completion date: Dec 31, 2021 to Jun 30, 2022
    v4
  6. 2 versions Re-verified since Jan 30, 2019, no change to tracked fieldsv2-v3
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.
Trial Details
NCT Number NCT03288948
Lead Sponsor Retina Foundation of the Southwest
Collaborators: National Eye Institute (NEI)
Conditions
(from sponsor)		 Amblyopia
Related terms Amblyopia
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov